CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.0B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
56.28 12.23 12.46 29.31 17.19 12.46 14.60 0.00 11.35 16.27
Piotroski F-Score
7 6 7 7 7 6 6 4 7 7
P/S ratio
0.25 0.15 0.29 0.38 0.47 0.33 0.38 0.35 0.41 0.49
Altman Z-Score
2.26 2.05 2.26 2.32 2.25 1.97 1.97 1.65 3.69 3.76
Altman Z″-Score (non-manufacturers)
0.99 1.07 1.34 1.41 1.43 1.40 1.36 1.30 2.90 3.09
P/FCF ratio
12.88 8.93 9.99 9.06 8.64 6.66 9.30 10.02 12.32 10.89
Beneish M-Score
(2.64) (2.61) (2.34) (2.62) (2.60) (2.58) (2.62) (2.45) (2.47) (2.72)
P/Operating CF
29.66 30.39 (39.41) (62.45) 33.97 25.06 36.69 27.59 (551.40) 40.65
Dividend Safety Score
43 — — — — — — — — —
P/B ratio
1.33 0.75 1.36 1.70 1.81 1.28 1.51 1.17 1.99 2.34
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.38 0.30 0.43 0.49 0.62 0.53 0.61 0.70 0.54 0.62
EV/EBITDA
10.31 8.53 8.51 13.01 9.86 7.80 9.60 10.49 8.21 8.58
EV/Operating CF
14.52 12.28 11.47 9.79 9.84 9.03 12.23 15.26 12.51 10.88
EV/FCF
19.79 17.67 14.82 11.78 11.41 10.66 15.12 19.81 16.45 13.93
Quick Ratio
0.57 0.56 0.59 0.62 0.55 0.53 0.52 0.55 0.49 0.60
Current Ratio
0.84 0.81 0.86 0.95 0.89 0.91 0.94 1.03 1.02 1.18
Net Debt/EBITDA
3.60 4.22 2.77 3.00 2.39 2.93 3.69 5.19 2.07 1.87
Debt/Assets
25.47% 26.17% 24.67% 22.89% 24.11% 28.02% 30.78% 37.38% 28.38% 29.15%
Debt/Equity
0.86 0.88 0.80 0.73 0.75 0.93 1.07 1.25 0.72 0.75
Asset Turnover
1.59 1.48 1.50 1.40 1.26 1.19 1.23 1.33 1.95 1.90
Operating CF/Net income
6.02 1.97 1.61 3.75 2.28 2.21 1.94 (14.92) 1.21 1.91
Capex/Depreciation
(0.27) (0.60) (0.69) (0.65) (0.51) (0.55) (0.56) (0.23) (0.72) (0.90)
Interest Coverage
1.49 2.88 5.17 3.48 5.32 4.79 3.95 1.54 8.98 9.63
ROE
2.34% 6.06% 11.24% 5.86% 11.03% 10.73% 10.81% (1.23%) 17.77% 14.36%
ROA
0.70% 1.83% 3.49% 1.87% 3.45% 3.17% 3.17% (0.41%) 6.99% 5.69%
ROIC
2.25% 4.06% 6.77% 4.59% 6.99% 7.04% 6.01% 2.00% 9.48% 10.66%
Return on Tangible Assets
(197.54%) (155.30%) 450.54% 47.45% 156.97% 103.18% 73.36% (4.72%) 60.90% 35.52%
Average Days of Receivables
36.11 35.71 35.94 30.87 30.53 29.53 27.89 33.07 26.04 25.01
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.44 0.47 0.48 0.45 0.46 0.48 0.51 0.59 0.55 0.55
Share Based Compensation of Revenue
0.13% 0.14% 0.16% 0.14% 0.17% 0.15% 0.18% 0.14% 0.13% 0.13%
Graham Net Nets
(1.03) (1.93) (1.01) (0.75) (0.72) (1.17) (1.12) (1.35) (0.35) (0.31)
Graham Number
43.45 70.48 93.32 62.46 87.84 81.03 75.16 0.00 73.40 61.77
Earnings Yield
1.78% 8.18% 8.03% 3.41% 5.82% 8.02% 6.85% (0.84%) 8.81% 6.15%
Free Cash Flow Yield
7.76% 11.19% 10.01% 11.03% 11.57% 15.02% 10.75% 9.98% 8.12% 9.18%
Revenue per Share
317.34 296.12 278.42 245.78 221.46 205.28 197.37 186.38 181.16 165.47
Operating CF per Share
8.40 7.23 10.45 12.33 13.85 12.12 9.88 8.49 7.85 9.45
Capex per Share
(2.24) (2.21) (2.36) (2.08) (1.91) (1.86) (1.89) (1.95) (1.88) (2.07)
Free Cash Flow per Share
6.16 5.02 8.09 10.25 11.94 10.26 7.99 6.54 5.97 7.38
Cash per Share
8.36 8.73 8.91 11.98 9.50 8.29 6.19 6.30 1.77 3.22
Shareholders Equity per Share
59.50 60.15 59.64 54.70 57.15 53.25 49.32 56.08 36.96 34.33
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
59.50 60.15 59.64 54.70 57.15 53.25 49.32 56.08 36.96 34.33
Free Cash Flow
7,807.00 6,326.00 10,395.00 13,450.00 15,745.00 13,428.00 10,391.00 6,828.00 6,089.00 7,917.00
Working Capital
(13,978.00) (15,964.00) (11,331.00) (3,788.00) (7,799.00) (5,648.00) (3,001.00) 1,234.00 581.00 4,792.00
Capital Expenditures
(2,832.00) (2,781.00) (3,031.00) (2,727.00) (2,520.00) (2,437.00) (2,457.00) (2,037.00) (1,918.00) (2,224.00)
Net Current Asset Value
(103,442.00) (108,840.00) (105,234.00) (90,873.00) (97,610.00) (104,645.00) (107,977.00) (92,670.00) (26,207.00) (26,586.00)
EV/EBIT
33.16 13.13 11.21 19.92 13.50 10.29 13.10 33.64 10.50 10.62
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Price to Operating Income
21.58 6.64 7.56 15.33 10.22 6.43 8.06 17.01 7.86 8.30
Other line items
Depreciation/Fixed assets
0.79 0.35 0.33 0.33 0.38 0.35 0.36 0.78 0.26 0.24
Cash ROIC
5.19% 4.13% 6.94% 9.62% 10.93% 9.25% 7.38% 4.93% 9.16% 11.67%
Accounts Receivable Turnover
10.55 10.40 11.45 12.47 12.65 12.99 13.79 12.63 14.58 14.76
Accounts Payable Turnover
13.19 13.40 14.60 14.38 14.85 15.16 16.35 17.59 18.26 18.99
Inventory Turnover
11.84 11.42 11.70 10.69 9.70 9.11 9.35 9.86 10.21 10.19
Average Days of Payables
29.11 28.12 25.05 27.51 26.04 24.79 24.13 20.82 21.08 19.79
Days of Inventory on Hand
31.76 32.04 30.30 35.39 36.87 41.17 40.28 38.38 36.38 36.77
Average Receivables
38,124.00 35,848.00 31,251.50 25,853.50 23,086.50 20,679.50 18,624.00 15,406.00 12,672.50 12,026.00
Average Payables
16,766.50 15,394.50 14,867.50 13,691.00 11,841.00 10,815.00 9,708.50 8,894.00 8,404.50 7,718.00
Average Inventory
18,676.50 18,066.00 18,557.50 18,425.00 18,128.00 18,006.00 16,983.00 15,873.00 15,028.00 14,380.50
Average Assets
253,376.50 251,471.50 239,001.50 230,637.00 231,857.00 226,582.00 209,452.50 145,793.50 94,796.50 93,449.50
Average Common Equity
75,556.00 76,183.00 74,202.50 73,575.00 72,541.00 66,935.50 61,356.50 48,119.00 37,264.50 37,018.50

Fold the line items

Columns are period end dates